Chiropractors in Bernalillo, NM Accepting Medicare

2 Chiropractors found. Showing 1 - 2

Dr. Tracy A. Marquez, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 965 W Highway 550 Ste C, Bernalillo, NM 87004 Phone: 505-860-1418

Inline Chiropractic Corporation Chiropractor Medicare: Medicare Enrolled Practice Location: 965 W Hwy 550 Ste C, Bernalillo, NM 87004 Phone: 505-867-3322

News Archive

First DNA-based blood test to help detect cystic fibrosis

The Food and Drug Administration (FDA) has approved the first DNA-based blood test to help detect cystic fibrosis. The Tag-It Cystic Fibrosis Kit directly analyzes human DNA to find genetic variations indicative of the disease. The test will be used to help diagnose cystic fibrosis in children and to identify adults who are "carriers" of the gene variations.

Viewpoints: Rep. Ryan says entitlements hold the key to an agreement; health law's impact on smokers; WSJ on Medicaid expansion

Once those threats are removed, however, there is plenty to discuss: how to replace the sequester cuts, which are already devastating domestic programs and are about to get much worse for defense spending; how to use fiscal policy to stimulate the creation of jobs and fix the nation's infrastructure; how to repair a broken tax system, reduce long-term debt, and ensure that social welfare programs remain healthy (10/8).

Meditrina licensor AstraZeneca granted US allowance of patent for endometriosis treatment

Meditrina Pharmaceuticals, Inc., a clinical-stage, specialty pharmaceutical company focused on developing and commercializing innovative therapies that treat women's reproductive system disorders, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Composition Comprising a Combination of an Aromatase Inhibitor, a Progestin, and an Oestrogen and its Use for the Treatment of Endometriosis" to the Company's licensor AstraZeneca.

Study finds PARP1 and EZH2 as potential therapeutic targets for small cell lung cancer

Newly discovered molecular differences between small cell lung cancer and nonsmall cell lung cancer have revealed PARP1 and EZH2 as potential therapeutic targets for patients with small cell lung cancer, according to the results of a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

Read more Medical News

› Verified 7 days ago